Arginine to glutamine substitutions in the fourth module of Xenopus interphotoreceptor retinoid-binding protein.

PURPOSE: Interphotoreceptor retinoid-binding protein (IRBP) is unusual for a lipid-binding protein in that its gene is expressed uniquely by cells of photoreceptor origin and consists of four homologous repeats, each coding for a module of approximately 300 amino acid residues. All-trans retinol binding domains, which appear to be present in each module, are composed of conserved hydrophobic regions [Baer et al, Exp Eye Res 1998; 66:249-262]. Here we investigate the role of highly conserved arginines contained in these regions. METHODS: To study the arginines in an individual module without the interference of ligand-binding activity elsewhere in the protein, we expressed in E. coli the fourth module of Xenopus IRBP by itself as a soluble thioredoxin fusion protein (X4IRBP). Arginines 1005, 1041, 1073 and 1122 were separately replaced by glutamine using PCR overlap extension mutagenesis. The glutamine substitutions were confirmed by liquid chromatography-tandem mass spectrometry. The binding of all-trans retinol and 9-(9-anthroyloxy)stearic acid (9-AS) to X4IRBP and each of the mutants was evaluated by fluorescence spectroscopy. Binding was followed by monitoring the enhancement of ligand fluorescence and the quenching of protein endogenous fluorescence. The ability of the recombinant proteins to protect all-trans retinol from oxidative degradation was evaluated by monitoring absorbance at 325 nm over time. RESULTS: The substitution of Gln for Arg1005 about doubled the amount of ligand necessary to attain saturation and about doubled the level of fluorescence enhancement obtained at saturation for both all-trans retinol and 9-AS. Although there was not a significant change in the Kd, the substitution increased the calculated number of binding sites (N) from approximately 2 to approximately 4 per polypeptide. The other Arg->Gln mutants did not significantly change the Kd or N. None of the mutations compromised the ability of the module to protect all-trans retinol from degradation. CONCLUSIONS: Our data suggest that the function of the conserved arginines in IRBP is fundamentally different from that of other retinoid-binding proteins. These residues do not appear to play a role in defining the specificity of the ligand-binding domain. Rather, Arg1005 appears to play a role in defining the capacity of the domain. Our data suggest that the binding site consists of a single hydrophobic cavity promiscuous for fatty acids and all-trans retinol.

Real-time flexible preventive maintenance scheduling.

There are still obstacles to overcome as we enter the programming phase of this project. We envision an automated system, similar to an expert system, that performs the interval/history analysis and makes the changes. Initially a field will need to be added to the inventory to denote whether a device belongs to one of the previously described groups that are exempt from interval changes. An intermediate step will be the formatting of a periodic report showing equipment that meets the change criteria as described in the two rules. For now, the actual changes would be reviewed and made by our management and technical staff. This report would be retained as documentation of the basis for each change, for our own benefit and to meet JCAHO requirements. We are still discussing whether the repair count should include all repairs (user error, abuse, unpredictable failure, etc.) or just those that are "significant and preventable" and could have been averted by PM. This is perhaps a question whose answer might vary from hospital to hospital, depending upon size and patient mix. With more emphasis being placed on process outcomes, on quality of work, and on getting the most benefit for our efforts, we believe our flexible, real-time PM scheduling program is a major step in the right direction. It is outcome-driven and it focuses resources where they are needed the most.